Guillain-Barre syndrome: symptoms, treatment, and when to worry
Last updated September 3, 2026.
Guillain-Barre syndrome is when the immune system, usually in the weeks after an infection, attacks the nerves, causing weakness that starts in the feet and legs and climbs upward over days. It is rare and it is a hospital emergency, because the weakness can reach the breathing muscles. With treatment, most people recover well, though recovery is measured in weeks to months.
What does it look like?
The typical start is tingling and numbness in the feet and hands, followed by weakness in the legs that rises over days: heavy legs, trouble climbing stairs, then unsteady walking, and sometimes difficulty with facial muscles, swallowing, or eye movements. Reflexes go quiet on examination. It commonly follows a diarrheal illness or a respiratory infection by one to three weeks. Pain in the back and legs is common. The speed of worsening is the defining feature.
What actually helps?
- Hospital immediately: suspected Guillain-Barre is admitted, because the course over the coming days cannot be predicted and breathing must be monitored.
- Two proven treatments: IV immunoglobulin (IVIG) or plasma exchange, started early, shorten the illness and improve recovery. Both work; the choice depends on the situation.
- Breathing monitoring: regular bedside breathing tests catch respiratory muscle weakness early, before it becomes dangerous.
- Rehabilitation is the long middle: physiotherapy and occupational therapy rebuild strength and independence as the nerves regrow, and most people walk again.
- Follow-up for the tail: fatigue, lingering numbness, and pain can persist after strength returns, and these are actively managed.
When is it an emergency?
Guillain-Barre is always an emergency while it is progressing. Call 911 or get to an emergency department now for weakness or tingling in the feet and legs that is worsening over days, especially after a recent infection, and immediately for any breathlessness, difficulty swallowing, choking, or inability to walk. In already-diagnosed patients, new breathing or swallowing trouble is a 911 call. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
What causes Guillain-Barre syndrome?
In most cases the immune system misfires after an infection, campylobacter food poisoning is the classic trigger, with flu-like illnesses and other infections also implicated, and antibodies meant for the germ cross-react with nerve insulation. The infection is usually one to three weeks behind you when the weakness starts. It is not contagious, not inherited, and not something anyone could have prevented.
How quickly does Guillain-Barre progress?
Fast by neurological standards: symptoms typically worsen over days, with most people reaching their worst point within about two weeks, and nearly all within four. That window is why suspected cases are admitted rather than given a follow-up appointment. Once progression stops, a plateau follows, then recovery begins. The pace of the first days is the single most telling diagnostic clue.
Will I recover from Guillain-Barre?
The large majority do. Most people walk again, and many return to normal or near-normal function, though recovery runs over months and sometimes up to a couple of years for the last deficits. Treatment with IVIG or plasma exchange improves the odds and the speed. Fatigue, residual numbness, and aches are common passengers on the way back and are actively managed in rehab.
What treatments exist for Guillain-Barre?
Two, and both are given early: IV immunoglobulin, an infusion of pooled antibodies that neutralizes the attack, and plasma exchange, which filters the attacking antibodies out of the blood. They work about equally well and are not combined. Everything else is support: breathing monitoring and ventilation if needed, blood clot prevention, pain control, and then rehabilitation as strength returns.
Can Guillain-Barre come back?
Recurrence after full recovery is rare. A small percentage of people have a second episode years later, and there is a related chronic condition, CIDP, where nerve inflammation persists or relapses and needs ongoing treatment. Worsening beyond about eight weeks, or a second decline after improvement, is the signal that the diagnosis may be the chronic form rather than classic Guillain-Barre.
Is Guillain-Barre linked to vaccines?
This is the honest version: a very small increase in Guillain-Barre risk has been observed after some vaccines in some seasons, famously the 1976 flu vaccine, and it is monitored continuously. The same risk, larger, follows the infections themselves, including flu and campylobacter. Current guidance weighs the tiny vaccine-associated risk against the much larger protection from the diseases. Any rapid-onset weakness after any trigger is the same emergency regardless.